Evidence map›Paper›PMID 39589981›Full record

ArticleBiosensors2024

Binding of Glutamic Acid to Silver and Gold Nanoparticles Investigated by Surface-Enhanced Raman Spectroscopy.

Vlasta Mohaček-Grošev, Marko Škrabić, Hrvoje Gebavi, Vesna Blažek Bregović, Ivan Marić, Vincenzo Amendola, Jože Grdadolnik

Abstract read
In one paragraph

Article in Biosensors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vlasta Mohaček-GroševCenter of Excellence for Advanced Materials and Sensing Devices, Research Unit New Functional Materials, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-8009-4822
Marko ŠkrabićDepartment of Physics and Biophysics, School of Medicine, University of Zagreb, Šalata bb, 10000 Zagreb, Croatia.ORCID 0000-0003-1173-2162
Hrvoje GebaviCenter of Excellence for Advanced Materials and Sensing Devices, Research Unit New Functional Materials, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-0982-1417
Vesna Blažek BregovićLaboratory for Optics and Thin Films, Division of Materials Physics, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.
Ivan MarićRadiation Chemistry and Dosimetry Laboratory, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0002-4546-7427
Vincenzo AmendolaDepartment of Chemical Sciences, University of Padova, I-35131 Padova, Italy.ORCID 0000-0002-9937-7005
Jože GrdadolnikNational Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0312-168X

Funding

Ministry of Scirence and Education of the Republic of Croatia croatian-slovenian bilateral project
6 · The paper itself

Abstract

Glutamate is the most important excitatory neurotransmitter, which is relevant for the study of several diseases such as amyotrophic lateral sclerosis and Alzheimer. It is the form L-glutamic acid (Glu) takes at physiologically relevant pHs. The surface-enhanced Raman spectra of Glu obtained at pH values ranging from 3.3 to 12 are collected in the presence of silver and gold colloids and on solid substrates. The observed bands are compared with the positions of calculated normal modes for free neutral glutamic acid, glutamic acid monohydrate, glutamic acid bound to gold and silver atoms, and sodium glutamate. Although gold atoms prefer to bind to the NH

Indexed as

Glutamic AcidGoldMetal NanoparticlesSilverSpectrum Analysis, RamanHydrogen-Ion ConcentrationGlutamic AcidGoldSilverAgNPAuNPCRYSTAL09glutamateglutamic acidnormal modessurface-enhanced Raman spectroscopy

Identifiers

PMID39589981
PMCPMC11591887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.